Craft

ROKIT Healthcare

Revenue

₩12.4 B

FY, 2023

ROKIT Healthcare Summary

Company Summary

Overview
ROKIT Healthcare (also known as Rokit) is a biotechnology company that develops 3D bioprinters and related products for organ and tissue regeneration. Its offerings include the Dr. Invivo AI Regen Platform and INVIVO bioprinters used to produce tissue grafts. The company serves medical institutions treating conditions such as diabetic foot ulcers, chronic kidney disease, and degenerative arthritis.
Type
Public
Status
Active
Founded
2012
HQ
Seoul, KR | view all locations
Website
https://rokithealthcare.com
Cybersecurity rating
Sectors

Key People

LocationsView all

3 locations detected

  • Seoul, Seoul HQ

    Korea (Republic of)

    Digital-ro 10-gil 9, Gasan High-hill Bldg. 12F

  • Los Angeles, CA

    United States

    11145 Tampa Ave

  • Saarbrücken, SL

    Germany

    Heinrich-Barth-Str. 1

ROKIT Healthcare Financials

Summary Financials

Revenue (Q3, 2024)
₩2.5B
Gross profit (Q3, 2024)
₩877.9M
Net income (Q3, 2024)
(₩1.7B)
Cash (Q3, 2024)
₩1.1B
EBIT (Q3, 2024)
(₩1.9B)

Footer menu